Antimicrobial resistance (AMR) is a growing crisis, causing 1.27 million deaths globally each year.

AMR surveillance in India faces fragmentation, especially between urban and rural areas. While cities have advanced diagnostics, rural regions lack basic testing.

India is shifting its focus to novel antibiotic development, as seen with Nafithromycin's recent emergence.

Misunderstandings about antibiotics, particularly their misuse for viral infections, are prevalent in India.

India’s engagement in global AMR efforts has grown, partnering with initiatives like WHO's GLASS. However, significant domestic challenges, including antibiotic overuse in agriculture, require specific local solutions to effectively combat AMR.

Experts predict streamlined diagnostics could reduce AMR-related deaths by 10-15% by 2030 in India.

India’s AMR action plan focuses on five key areas: enhancing surveillance, accelerating research, strengthening stewardship, asserting global leadership, and safeguarding the environment.